Pfizer Pay-For-Delay Claims Get 2nd Chance

Law360, New York (December 17, 2013, 8:18 PM EST) -- A Pennsylvania judge on Friday reinstated two claims he had cut from a suit against Mutual Pharmaceutical Co. Inc. and Pfizer Inc. unit King Pharmaceuticals Inc. over their alleged pay-for-delay deal preventing a generic form of King's muscle relaxant Skelaxin from hitting the market.

Judge Albert Snite Jr. revived the conspiracy and contract-interference claims that a researcher had filed against the drug makers, a Mutual executive and several of the company’s affiliates alleging the generic-suppressing accord caused him to lose out on royalties he would’ve made...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.